Premier Biomedical Inc
OTC:BIEI

Watchlist Manager
Premier Biomedical Inc Logo
Premier Biomedical Inc
OTC:BIEI
Watchlist
Price: 0.0004 USD Market Closed
Market Cap: 520k USD

Net Margin

-2 618.9%
Current
No historical data
Comparison unavailable

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-2 618.9%
=
Net Income
$-374.5k
/
Revenue
$14.3k

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-2 618.9%
=
Net Income
$-374.5k
/
Revenue
$14.3k

Peer Comparison

Country Company Market Cap Net
Margin
US
Premier Biomedical Inc
OTC:BIEI
520k USD
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
378.3B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
178.1B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
154.2B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.3B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.3B USD
Loading...
AU
CSL Ltd
ASX:CSL
85.3B AUD
Loading...
NL
argenx SE
XBRU:ARGX
41.7B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
46.9B USD
Loading...
No Stocks Found

Market Distribution

Lower than 95% of companies in the United States of America
Percentile
5th
Based on 15 072 companies
5th percentile
-2 618.9%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Premier Biomedical Inc
Glance View

Market Cap
520k USD
Industry
Biotechnology

Premier Biomedical, Inc. is a research-based company, which engages in the development and discovery of medical products. The company is headquartered in Whitefish, Montana. The company went IPO on 2012-02-23. The firm has developed a line of topical hemp oil pain relief products. The firm develops medical treatments for humans, specifically focusing on the treatment of Cancer Fibromyalgia, Traumatic Brain Injury (TBI), Alzheimer’s Disease (AD), Blood Sepsis and Viremia, Feldetrex. The firm offers eight pain relief products: 96-hour pain relief patch with 50 mg of hemp oil extract, 120 milligram (mg)/ 10 milliliter (ml) water-based roll-on applicator; 150 mg/ 30 ml oil-based pump spray applicator; 150 mg/ 2 oz. ointment; 200 mg/10 ml oil-based roll-on applicator; 500 mg/ 30 ml oil-based pump-spray applicator, and 500 mg/ 1 oz. ointment. The company offers extra-corporeal treatment of disease, PTSD treatment, anti-breast cancer drugs, hemp oil, anti-aging treatments and chemical and alcohol addiction treatment.

BIEI Intrinsic Value
Not Available
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-2 618.9%
=
Net Income
$-374.5k
/
Revenue
$14.3k
How has Net Margin changed over time?

Over the last 2 years, Premier Biomedical Inc’s Net Margin has increased from -15 300% to -2 618.9%. During this period, it reached a low of -15 300% on Sep 30, 2017 and a high of 5 466.7% on Jun 30, 2018.

Back to Top